









Markets
/
Stocks
/
nasdaq-sint
/

SINTX Technologies Inc

SINT

4.930USD

+0.710+16.82%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

12.26MMarket Cap

LossP/E TTM



SINTX Technologies Inc

4.930

+0.710+16.82%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

139 / 207

Overall Ranking

364 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

28.000

Target Price

+563.51%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

SINTX Technologies, Inc. is an advanced ceramics company. The Company is focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. The Company is focusing primarily on the research, development and commercialization of medical devices manufactured with silicon nitride. The Company is manufacturing, research, and development of products comprised from advanced ceramic materials for external partners. It produces silicon nitride for use in its commercial products and product candidates in various forms: solid silicon nitride, porous silicon nitride, silicon nitride powder, composites of silicon nitride and PEEK and PEKK and silicon nitride coating. It is also focused on development and manufacturing ceramics for personnel, aircraft, and vehicle armor. Its silicon nitride products can be polished to a smooth and wear-resistant surface for articulating applications, such as bearings for hip and knee replacements.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 84.95% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 2.89M.

Undervalued

The company’s latest PE is -0.59, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 461.18K shares, increasing 45.19% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 30.43K shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 5.62, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 151.00K, representing a year-over-year decrease of 82.42%, while its net profit experienced a year-over-year decrease of 5.17%.

Score

Industry at a Glance

Previous score

5.62

Change



Financials

7.40

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.65

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

3.17

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.10

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.50, which is -94.69% below the recent high of -0.03 and 59.58% above the recent low of -0.20.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 139/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for SINTX Technologies Inc is 28.00, with a high of 28.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

28.000

Target Price

+563.51%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

SINTX Technologies Inc

SINT

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 1.43, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 6.30 and the support level at 2.62, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.43

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.091

Neutral

RSI(14)

61.000

Neutral

STOCH(KDJ)(9,3,3)

57.999

Buy

ATR(14)

0.781

High Vlolatility

CCI(14)

42.693

Neutral

Williams %R

63.400

Sell

TRIX(12,20)

1.259

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

4.289

Buy

MA10

4.352

Buy

MA20

4.310

Buy

MA50

3.438

Buy

MA100

3.215

Buy

MA200

3.196

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 17.81%, representing a quarter-over-quarter increase of 25.45%. The largest institutional shareholder is The Vanguard, holding a total of 30.43K shares, representing 1.10% of shares outstanding, with 6708.64% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Medtech Ceramics LP

250.08K

Honigblum (Gregg R.)

14.00K

Olson Eric K

14.50K

The Vanguard Group, Inc.

Star Investors

30.43K

+13858.72%

Geode Capital Management, L.L.C.

11.49K

+65.84%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.07, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.83. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.